Welcome to MCL!

This is the Consortium for Molecular and Cellular Characterization of Screen-Detected Lesions.

The MCL Consortium consists of independent, multi-disciplinary teams that undertake comprehensive molecular and cellular characterizations of tumor tissue, cell, and microenvironment components to distinguish screen-detected early lesions from interval and symptom-detected cancers.

If you'd like to join us, fill out the registration form.


 

COMING UP SOON:

MCL 8th Semiannual Steering Committee Meeting

The MCL Consortium will hold its 8th Face-to-Face Steering Committee Meeting in San Diego, CA - October 2 - 4, 2019 at the San Diego Marriott La Jolla. 

The meeting will begin on Wednesday, Oct 2 in the afternoon with the MCL Pathology Working Group Image Analysis Meeting, followed by the Data, Informatics and Resource Sharing Committee meeting and working dinner. 

Agenda

San Diego Meeting Registration

San Diego Marriott La Jolla Reservations